HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

False negative hydroxyamphetamine test in horner syndrome caused by acute internal carotid artery dissection.

AbstractA patient with Horner syndrome from internal carotid artery dissection initially had a false negative hydroxyamphetamine test. Two months later, the ophthalmic signs had disappeared but the hydroxyamphetamine test was positive. This case illustrates that hydroxyamphetamine testing may be falsely negative in acute Horner syndrome because norepinephrine stores in oculosympathetic postganglionic terminals have not yet been depleted. However, the hydroxyamphetamine test may be positive even after the ophthalmic signs of Horner syndrome have disappeared.
AuthorsMark L Moster, David Galiani, William Garfinkle (Affiliation: Department of Neurosensory Sciences, Albert Einstein Medical Center, Philadelphia, USA. mmoster at aol.com)
JournalJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society (J Neuroophthalmol) Vol. 23 Issue 1 Pg. 22-3 (Mar 2003) ISSN: 1070-8022 [Print] United States
PMID12616084 (Publication Type: Case Reports, Journal Article)
Chemical References
  • p-Hydroxyamphetamine
  • Warfarin
Topics
  • Adult
  • Anisocoria (physiopathology)
  • Carotid Arteries (surgery)
  • Dissection (adverse effects)
  • False Negative Reactions
  • Hemorrhage (physiopathology)
  • Horner Syndrome (diagnosis, etiology)
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Warfarin (therapeutic use)
  • p-Hydroxyamphetamine (diagnostic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD